NAA is an N‑acetylated derivative of aspartic acid and falls into the biochemical category of amino‑acid metabolites. It is synthesized in neurons by transfer of an acetyl group from acetyl‑CoA and is one of the most abundant small molecules in the healthy brain. Clinically, NAA has long been studied as a marker of neuronal metabolic activity using techniques such as magnetic resonance spectroscopy, and it appears in peripheral fluids when central metabolic handling or cellular turnover shifts. Biologically, NAA serves multiple proposed roles: as an osmolyte that helps regulate cell volume, as a source of acetate for oligodendrocytes and myelin lipid metabolism, and as a reporter of neuronal mitochondrial acetyl‑group use. Its levels integrate neuronal synthetic activity, mitochondrial function, and aspects of intercellular metabolite trafficking.

Elevated urinary NAA may reflect increased neuronal turnover, altered release or clearance of neuronal metabolites, or shifts in mitochondrial acetyl‑group handling that increase peripheral excretion. Lower-than-expected NAA can be associated with reduced neuronal metabolic activity or impaired synthesis and may signal lowered mitochondrial acetylation processes. Interpretation requires the full Cellular Zoomer context—mitochondrial intermediates, oxidative stress markers, and related neurotransmitter and nutrient indicators—to distinguish between altered production, breakdown, or clearance patterns.

NAA is included in the Cellular Zoomer to probe neuronal metabolic activity and mitochondrial acetyl-group dynamics noninvasively. Paired with energy‑cycle and redox markers, urinary NAA helps map whether changes reflect production, turnover, or clearance, supporting a more personalized view of cellular and neuro‑metabolic balance.